Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,344 | 35,952 | 43,806 | 33,938 | 41,744 |
| TOTAL | $28,977 | $36,714 | $44,967 | $34,463 | $44,269 |
| Non-Current Assets | |||||
| PPE Net | 13,927 | 13,863 | 13,426 | 12,769 | 12,330 |
| Other Non-Current Assets | 18 | 18 | 18 | 18 | 18 |
| TOTAL | $13,945 | $13,881 | $13,444 | $12,787 | $12,348 |
| Total Assets | $42,922 | $50,595 | $58,411 | $47,250 | $56,617 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,161 | 13,391 | 9,013 | 8,967 | 8,962 |
| Accrued Expenses | 1,130 | 852 | 1,857 | 1,186 | 2,567 |
| Other current liabilities | 22 | 29 | 90 | 70 | 63 |
| TOTAL | $12,313 | $14,272 | $10,960 | $10,223 | $11,592 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 5,887 | 7,886 | 9,416 |
| TOTAL | $N/A | $N/A | $5,887 | $7,886 | $9,416 |
| Total Liabilities | $12,313 | $14,272 | $16,847 | $18,109 | $21,008 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17 | 17 | 17 | 14 | 14 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -228,605 | -221,772 | -215,532 | -208,429 | -200,984 |
| TOTAL | $30,609 | $36,323 | $41,564 | $29,141 | $35,609 |
| Total Liabilities And Equity | $42,922 | $50,595 | $58,411 | $47,250 | $56,617 |